159847-81-1

Basic information

• Product Name: METHYL 2-AMINO-5-CYANOBENZOATE
• Synonyms: METHYL 2-AMINO-5-CYANOBENZOATE;2-Amino-5-cyanobenzoic acid methyl ester;Methyl 2-amino-5-cyanobenzoate≥ 97% (HPLC)
• CAS NO: 159847-81-1
• Molecular Formula: C₉H₈N₂O₂
• Molecular Weight: 176.17202
• Mol File: 159847-81-1.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 334.08°C at 760 mmHg
• Flash Point: 155.846°C
• Appearance: /
• Density: 1.262g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.574
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 0.95±0.10(Predicted)
• CAS DataBase Reference: METHYL 2-AMINO-5-CYANOBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-AMINO-5-CYANOBENZOATE(159847-81-1)
• EPA Substance Registry System: METHYL 2-AMINO-5-CYANOBENZOATE(159847-81-1)

Safety Data

• Hazardous Substances Data: 159847-81-1(Hazardous Substances Data)

Usage

Chemical Properties

Pale yellow crystalline powder

InChI:InChI=1/C9H8N2O2/c1-13-9(12)7-4-6(5-10)2-3-8(7)11/h2-4H,11H2,1H3

Upstream product

• 5794-88-7 5-Bromo-2-aminobenzoic acid 
• 134-20-3 2-carbomethoxyaniline 
• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 33348-34-4 4-amino-3-iodobenzonitrile 
• 99767-45-0 2-amino-5-cyanobenzoic acid 
• 52727-57-8 5-bromo-2-aminobenzoic acid methyl ester 
• 544-92-3 copper(I) cyanide 
• 615-57-6 2,4-dibromo-aniline 
• 19619-22-8 2,4-dicyanoaniline 

Downstream Products

• 195717-63-6 methyl 2-amino-5-(aminomethyl)benzoate 
• 640280-29-1 methyl 5-cyano-2-{[2-{[4-cyano-2-(methoxycarbonyl)phenyl]amino}-4-(trifluoromethyl) phenyl]amino}benzoate 
• 668261-66-3 methyl 2-{[3-(chlorosulfonyl)benzoyl]amino}-5-cyanobenzoate 
• 668261-40-3 methyl 2-({3-[(5-chloro-2,3-dihydro-1H-indol-1-yl)sulfonyl]-2-methylbenzoyl}amino)-5-cyanobenzoate 
• 668262-45-1 methyl 5-cyano-2-{[3-(pyrrolidin-1-ylsulfonyl)benzoyl]amino}benzoate 
• 668261-64-1 methyl 5-cyano-2-{[3-(2,5-dimethylpyrrolidin-1-ylsulfonyl)benzoyl]amino}benzoate 
• 668261-72-1 methyl 5-cyano-2-{[3-(piperidin-1-ylsulfonyl)benzoyl]amino}benzoate 
• 668261-90-3 methyl 2-[(3-{[{2-[(tert-butoxycarbonyl)amino]phenyl}(methyl)amino]sulfonyl}benzoyl)amino]-5-cyanobenzoate 
• 1354560-51-2 methyl 2-[(4-{[(4-chlorophenyl)(methyl)amino]sulfonyl}benzoyl)amino]-5-cyanobenzoate 
• 668261-56-1 methyl 5-cyano-2-{[4-(pyrrolidin-1-ylsulfonyl)benzoyl]amino}benzoate 
• 1428482-14-7 2-bromo-5-thiocarbamoyl-benzoic acid methyl ester 
• 1428482-15-8 2-bromo-5-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-benzoic acid methyl ester 
• 1428482-16-9 4-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-biphenyl-2,4'-dicarboxylic acid 4'-tert-butyl ester 2-methyl ester 
• 1428482-17-0 4-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-biphenyl-2,4'-dicarboxylic acid 2-methyl ester 

Relevant articles and documents

INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES

Compounds of Formula I and Formula II: pharmaceutical compositions containing them, and use of the compounds as active ingredients to treat infection with alphavirus.

Triketone-based compound preparation method

The invention relates to the field of preparation of pesticides, and discloses a triketone-based compound preparation method, wherein the triketone-based compound has a structure represented by a formula (1). The method comprises that 1) a compound represented by a formula (2), 1,3-cyclohexanedione and CO are subjected to a reaction in the presence of a first catalyst under an alkali condition toobtain a product represented by a formula (3); and 2) the product represented by the formula (3) contacts a second catalyst and an alkali substance under a rearrangement reaction condition to obtain the triketone-based compound represented by the formula (1). According to the present invention, with the method, the triketone-based compound can be obtained in the low-cost and high-yield manner; andthe purity of the triketone-based compound obtained through the method is high. The formulas (1), (2) and (3) are defined in the specification.

6-SUBSTITUTED QUINAZOLINONE INHIBITORS

The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for exa